Compare Canopy Growth Corp (CGC) vs Dollar General Corp. (DG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Canopy Growth Corp vs Dollar General Corp. — how do they compare? Canopy Growth Corp trades at $1.03 (market cap $421.10M), while Dollar General Corp. trades at $119.29 (market cap $26.49B). The key difference: Dollar General Corp. is far larger — about 62.9× Canopy Growth Corp's market cap, and Dollar General Corp. pays a 1.97% dividend while Canopy Growth Corp pays none. Which is the better fit depends on your goals.
| CGC | DG | |
|---|---|---|
Market Cap | $421.10M | $26.49B |
Sector | Health | Consumer Staples |
52-Week High | $1.92 | $156.26 |
52-Week Low | $0.86 | $95.94 |
Enterprise Value | $378.55M | $40.93B |
Dividend Yield | — | 1.97% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Canopy Growth (CGC) trades at $1.025, up 7.66% with bullish technical signals. The company shows improving fundamentals with Q1 2027 revenue growth of 13% and narrowing losses. Recent acquisitions and cost-cutting initiatives support expansion in medical and European cannabis markets. The stock trades below book value (P/B 0.86) while maintaining a P/S ratio of 1.71.
CGC presents a high-risk turnaround opportunity with improving balance sheet metrics and positive revenue momentum. However, persistent negative earnings and cash flow challenges require careful monitoring. Analyst sentiment remains divided with 33% buy ratings, reflecting the speculative nature of cannabis sector investments amid ongoing regulatory uncertainty.
Dollar General (DG) trades at $119.65, down 2.24% amid broader market weakness. The stock shows strong fundamentals with a P/E of 16.98 and P/S of 0.62, trading below analyst consensus target of $128.45. Recent earnings beats and positive cash flow trends ($395M net in 2025) support the bullish case, though profit margins have compressed from 7.01% in 2022 to 2.77% in 2025. Technical indicators show mixed signals with bullish overall sentiment but bearish moving averages.
Outlook remains positive given 52% analyst buy ratings and projected earnings growth, but investors face margin pressure and competitive threats from Walmart and Amazon. The stock offers value characteristics with upside to price targets, though same-store sales growth and cost management will be critical for sustained performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Canopy Growth Corp
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →About Dollar General Corp.
A leading American discount retailer, Dollar General operates over 18,000 stores in 47 states, selling branded and private-label products across a wide variety of categories. In fiscal 2021, 77% of net sales came from consumables (including paper and cleaning products, packaged and perishable food, tobacco, and health and beauty items), 12% from seasonal merchandise (such as toys, greeting cards, decorations, and gardening supplies), 7% from home products (for example, kitchen supplies, small appliances, and cookware), and 4% from basic apparel. Stores average roughly 7,400 square feet, and about 75% of Dollar General locations are in towns of 20,000 or fewer people. The firm emphasizes value, with most of its items sold at everyday low prices of $5 or less.
Read more on DG →
